The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s pseudomonas aeruginosa infection treatment market report forecasts the pseudomonas aeruginosa infection treatment market size to grow to $3.07 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Pseudomonas Aeruginosa Infection Treatment Market Report 2023 – https://www.thebusinessresearchcompany.com/report/pseudomonas-aeruginosa-infection-treatment-global-market-report

Pseudomonas Aeruginosa Infection Treatment Market Size Forecast
The global pseudomonas aeruginosa infection treatment market is expected to grow from $2.10 billion in 2022 to $2.27 billion in 2023 at a compound annual growth rate (CAGR) of 8.40%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global pseudomonas aeruginosa infection treatment market size is expected to reach $3.07 billion in 2027 at a CAGR of 7.79%.

Europe held the largest pseudomonas aeruginosa infection treatment market share, and North America was the fastest-growing region in 2022.

Key Pseudomonas Aeruginosa Infection Treatment Market Driver ­– Increase In The Incidence Of Co-Morbidities Such As Pneumonia, Cystic Fibrosis, Urinary Tract Infection, And Bloodstream Infection
According to an article published in August 2022 by the National Library of Medicine, a US-based biomedical library and the centre of computational biology and biomedical informatics, the annual incidence rate of community-acquired pneumonia in the US is 24.8 cases per 10,000 adult population, with rates rising with age. Pneumonia is the eighth highest cause of death and the most common infectious cause of death. Patients admitted to the intensive care unit have a fatality rate of up to 23%. As a result, the rising prevalence of co-morbidities such as pneumonia, cystic fibrosis, urinary tract infection, and bloodstream infection is propelling the pseudomonas aeruginosa infection treatment market forward.

Request for A Sample Of The Global Pseudomonas Aeruginosa Infection Treatment Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=9174&type=smp

Key Pseudomonas Aeruginosa Infection Treatment Market Trend – Technological Advancement
To maintain their market position, major players are developing novel vaccines, biologics such as antimicrobial peptides and therapeutic antibodies, virulence inhibitors, antimicrobials with novel targets, antibody-drug conjugates, resistance inhibitor-antibiotic or antibiotic-potentiator combinations, and bacteriophages or phage-derived lysins. For example, in April 2021, the Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator, a global non-profit organisation based in the United States that supports antimicrobial research, will fund Phico Therapeutics, a UK-based biotechnology company, to develop a novel intravenous-designed bacteriophage medication to treat ventilator-associated pneumonia caused by Pseudomonas aeruginosa. Phico’s groundbreaking SASPject technology allows it to precisely target P. aeruginosa bacteria and inactivate their DNA, preventing them from reproducing and spreading. This is accomplished by combining modified bacterial viruses (bacteriophages) with antimicrobial tiny acid-soluble spores proteins (SASPs).

Pseudomonas Aeruginosa Infection Treatment Market Segment
1) By Medication: Monotherapy, Combination Therapy
2) By Drug Class: Aminoglycoside, Cephalosporin, Carbapenem, Monobactum, Other Drug Classess
3) By Route Of Administration: Nasal, Oral, Intravenous
4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Pseudomonas Aeruginosa Infection Treatment Market Major Players and Strategies
Major players in the pseudomonas aeruginosa infection treatment market are AbbVie Inc., Teva Pharmaceutical Industries Ltd., Merck & Co. Inc., Janssen Pharmaceutica NV, Pfizer Inc., Lupin Limited, AstraZeneca, Bristol Myers Squibb Company, Gilead Sciences Inc., Novartis Pharmaceuticals Corporation, F. Hoffmann-La Roche AG, Bayer AG, Aradigm Corporation, AmpliPhi Biosciences Corporation and Humanigen lnc.

Polyphor AG, a Swiss pharmaceutical business, will merge with EnBiotix Inc., a bioengineering company based in the United States, in December 2021. The combined company’s name has been changed to Spexis AG as a result of the merger, and it is intended to create a different approach as a rare illness and cancer enterprise with an innovative R&D pipeline, as well as engage in distinctive strategic corporate development.

The Pseudomonas Aeruginosa Infection Treatment Global Market Report 2023 covers regional data on pseudomonas aeruginosa infection treatment market size, pseudomonas aeruginosa infection treatment market trends and drivers, opportunities, strategies, and pseudomonas aeruginosa infection treatment market competitor analysis. The countries covered in the pseudomonas aeruginosa infection treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

Pseudomonas aeruginosa is a gram-negative aerobic rod bacteria from the pseudomonad family. These can be found in soil as well as water. In diagnostic labs, the microorganism is clinically significant. Pseudomonas aeruginosa can be transmitted by breathing apparatus, disinfectants, sinks, and patient-to-patient transfer.

View More Reports Related To The Pseudomonas Aeruginosa Infection Treatment Market –
Hospital Acquired Infections Testing Kits Global Market Report 2023
Benign Prostatic Hyperplasia (BPH) Treatment Devices And Equipment Global Market Report 2023
Polycystic Ovarian Syndrome Treatment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: